SOHN v. KOMINOX USA, INC.

CourtDistrict Court, D. New Jersey
DecidedApril 3, 2023
Docket2:21-cv-17526
StatusUnknown

This text of SOHN v. KOMINOX USA, INC. (SOHN v. KOMINOX USA, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SOHN v. KOMINOX USA, INC., (D.N.J. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MINSOO SOHN, Case No. 21–cv–17526–KSH–ESK Plaintiff,

v. OPINION AND ORDER KOMINOX USA, INC., et al., Defendants. KIEL, U.S.M.J. THIS MATTER having come before the Court on plaintiff Minsoo Sohn’s motion for leave to file a second amended complaint: (1) to add Komipharm International Co., Ltd. (Komipharm), Kominox Inc. (KMI), and Yong Jin Yang as defendants, and (2) to amend certain allegations (ECF No. 52); and defendants Kominox USA, Inc. (Kominox) and Yoonkon Yang having filed opposition to the motion (ECF No. 57);1 and Sohn not filing a reply; and the Court finding: 1. As set forth in the amended complaint filed by Sohn on September 24, 2021, Sohn was employed from June 2017 to August 2021 as “an office clerk who handled [paperwork] … and communicated with client companies in Korea and Australia” by Kominox, which is owned and operated by Yoonkon Yang. (ECF No. 2 pp. 2–4, 11.)2 According to Sohn, in addition to the clerk duties that he performed six days a week for at least 12 hours a day, he: (a) was expected to perform gardening, lawnmowing, snow clearance, cleaning, grocery shopping, and construction at Yoonkon Yang’s residence on Sundays; (b) was expected to work overnight and sleep in his office at various times; (c) acted as Yoonkon Yang’s driver for Yoonkon Yang’s social outings; (d) was expected to perform various favors for Yoonkon Yang’s alleged girlfriend; and (e) experienced physical and mental abuse by Yoonkon Yang. (Id. pp. 4–5.) Sohn alleges that Kominox and Yoonkon Yang compensated him with less than minimum wages and

1 Defendant Yoonkon Yang has been listed in the amended complaint, in the answer, and in a motion subsequently filed on his behalf. (ECF Nos. 2, 8, 22.) Sohn has alternatively spelled Yoonkon Yang’s name as Yoon Gon Yang (ECF No. 38) and as Yoonjkon Yang. (ECF No. 46 p. 1; ECF No. 52 p. 1.)

2 Sohn filed an amended complaint on the same day as the original complaint. (ECF Nos. 1, 2.) deprived him of overtime wages in violation of the Fair Labor Standards Act, the New Jersey Wage and Hour Law, and the New Jersey Wage Payment Law in view of the excessive hours that he was forced to work. (Id. pp. 1, 5–12.) 2. On January 20, 2022, Sohn, Kominox, and Yoonkon Yang submitted a joint discovery plan, wherein the parties agreed that “[f]actual discovery [was] to be completed by April 25, 2022,” and “[m]otions to [a]mend or to [a]dd [p]arties [were] to be filed by May 25, 2022.” (ECF No. 12 p. 2.) I conducted an initial scheduling conference on January 25, 2022, and counsel for Sohn was in attendance. (ECF No. 13 p. 1 (introductory paragraph).) On January 26, 2022, I issued an initial scheduling order (January 2022 Order), wherein I adopted the agreed-upon deadlines for: (a) fact discovery; and (b) adding new parties and amending the pleadings (Amendment Deadline). (Id. ¶¶ 4, 5 (providing “[f]act discovery is to remain open through April 25, 2022,” and “[m]otions to add new parties, whether by amended or third-party complaint, and motions to amend pleadings must be filed no later than May 25, 2022”).) 3. I conducted a status conference on May 3, 2022. (ECF No. 16 p. 1 (introductory paragraph).) In response to a joint letter request filed by Sohn, Kominox, and Yoonkon Yang on April 25, 2022 (ECF No. 14), I extended the deadline to conduct fact discovery to June 30, 2022. (ECF No. 16 ¶ 2.) No request to extend the Amendment Deadline was made, and I granted no such extension. 4. Yoonkon Yang filed a motion for leave to file a counterclaim (Counterclaim Motion) against Sohn on May 16, 2022, i.e., before the Amendment Deadline. (ECF No. 17.) I initially denied the Counterclaim Motion on May 23, 2022 without prejudice for reasons that did not address the merits, but I granted Yoonkon Yang leave to file a corrected motion. (ECF No. 20.) Yoonkon Yang refiled the Counterclaim Motion on June 23, 2022 (ECF No. 22), and I denied it on the merits on July 21, 2022. (ECF No. 29.) While the issues concerning the refiling and the resolution of the Counterclaim Motion were pending, Sohn, Kominox, and Yoonkon Yang filed a joint request on June 20, 2022 to extend the fact-discovery deadline to August 31, 2022. (ECF No. 21.) I granted that request on July 5, 2022. (ECF No. 25.) No request to extend the Amendment Deadline was made, and I granted no such extension. 5. I conducted status conferences on July 22, 2022 and on November 1, 2022. (ECF Nos. 30, 34.) Sohn, Kominox, and Yoonkon Yang submitted a joint status letter on October 28, 2022 stating they “[we]re not contemplating filing any motions at this time,” even though “[b]oth parties nonetheless reserve[d] the right to file motions as the case goes forward” (ECF No. 36 p. 3), but no request to extend the Amendment Deadline was made and I granted no such extension. Following the November 1, 2022 conference, I scheduled a status conference for January 25, 2023. (ECF No. 37.) 6. On December 16, 2022, seven months after the Amendment Deadline had lapsed, Sohn filed a letter request (December Letter Request) to file a second amended complaint: (a) to add only Komipharm and Yong Jin Yang as defendants in order to assert new claims against them for tacitly approving of the violative conduct directed toward Sohn by Kominox and Yoonkon Yang; and (b) to expand upon the allegations concerning the number of hours that he worked. (ECF No. 38.) Sohn did not request to extend the Amendment Deadline as part of the December Letter Request. (Id.) By an order filed on December 20, 2022 (December 2022 Order), I denied the December Letter Request without prejudice because it did not conform with the requirements of the Federal and Local Civil Rules, and I directed Sohn to attempt to file a proper motion by December 27, 2022. (ECF No. 39.) In response to Sohn’s letter request filed on December 27, 2022 (ECF No. 40), I extended the time to comply with the December 2022 Order to January 10, 2023. (ECF No. 41.) 7. On January 10, 2023, Sohn filed a purported motion for leave to file a second amended complaint (First January Motion To Amend) to, among other things, add only Komipharm and Yong Jin Yang as defendants, but Sohn did not request to extend the Amendment Deadline. (ECF No. 43.) On January 12, 2023, I administratively terminated the First January Motion To Amend because it did not conform with the requirements of the Local Civil Rules. (ECF No. 45.) Sohn filed a new motion for leave to file a second amended complaint on January 16, 2023 (Second January Motion To Amend) to, among other things, add only Komipharm and Yong Jin Yang as defendants. (ECF No. 46.) Between December 16, 2022 and January 16, 2023, including within Sohn’s papers submitted in support of the Second January Motion To Amend (id.), Sohn did not request to extend the Amendment Deadline. However, Sohn requested on January 10, 2023 to extend the deadline to conduct fact discovery to March 31, 2023. (ECF No. 42.) I granted that request on January 11, 2023. (ECF No. 44.) 8. In preparation for the January 25, 2023 status conference, Sohn, Kominox, and Yoonkon Yang filed a joint status letter on January 20, 2023. (ECF No. 48.) Sohn did not request to extend the Amendment Deadline in that letter. (Id.) 9. I conducted the January 25, 2023 status conference on the record. (ECF No. 53.) There was a discussion concerning the amount of time that had elapsed between the filing of the amended complaint, i.e., September 2021, and the first attempt to file a second amended complaint, i.e., December 2022. (Id. pp. 10, 11.) I also pointed out that the Second January Motion To Amend did not comply with Local Civil Rule 15.1 concerning the provision of a version of the proposed second amended complaint wherein all changes were to be accurately redlined. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
SOHN v. KOMINOX USA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/sohn-v-kominox-usa-inc-njd-2023.